Logo image
Prof. Dr. med. Claus-Henning Kohne working place, University Hospital Oldenburg
Prof. Dr. med. Claus-Henning Kohne
Excellent
AiroScore
9.60

Prof. Dr. med. Claus-Henning Kohne

hematology and internal oncology
hematology and internal oncology
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
92%39 years9.6/10$$$293No

Overview

Country, City
Germany, Oldenburg
Health facility
University Hospital Oldenburg
Medical unit
Department of oncology and hematology

About the doctor

Prof. Dr. med. Claus-Henning Kohne is a highly experienced doctor specializing in hematology and internal oncology. With 38 years of experience, he has established himself as a renowned expert. Dr. Kohne works at the Department of Oncology and Hematology at the University Hospital Oldenburg in Germany. Throughout his career, Dr. Kohne has made significant contributions to the field of oncology. He has published 284 scientific publications, focusing on various cancer treatment and management aspects. Some of his notable studies include the management of polyps, (neo)adjuvant therapy, and treating metastases in colorectal carcinoma. He has also researched the impact of different chemotherapy regimens on patients with advanced pancreatic cancer. Dr. Kohne's expertise is widely recognized, as he holds memberships in several prominent international organizations, such as the American Association of Cancer Research and the European Society of Medical Oncology. He has also served as a study coordinator for various clinical trials, including the Pan-European-Trial for Adjuvant Colon Cancer Initiative and the European Organization for Research and Treatment of Cancer Studies. With his extensive knowledge and dedication to improving cancer treatment, Prof. Dr. med. Claus-Henning Kohne is considered an exceptional doctor in hematology and internal oncology. His contributions have significantly impacted advancing our understanding and treatment of cancer.

Skills & Expertise

cancer
colorectal cancer
metastatic colorectal cancer
chemotherapy
cetuximab
5fluorouracil
irinotecan
metastases
leukemia
liver
myeloid leukemia
oncology
liver metastases
carcinoma
colon
leucovorin
panitumumab
colon cancer
elderly
hematology
breast
breast cancer
tumor
colorectal carcinoma
gemcitabine
gastric cancer
imatinib
internal oncology
rectal cancer
stem cell transplantation
celecoxib
lymphoma
metastatic colorectal carcinoma
pancreatic cancer
gefitinib
palliative therapy
her2positive breast cancer
colorectal metastases
mitomycin c
mdr1overexpressing breast cancer
pancreatic carcinoma
dendritic cells
metastatic breast cancer
rectal carcinoma
gastric carcinoma
gastrointestinal cancer
oesophageal cancer
urothelial cancer
lung cancer
rectum

Resume

CV (Curriculum Vitae)

Education
  • 1978-1985 Studied human medicine at the Hannover Medical School
  • 1982-1983 Training in internal medicine, hematology, and oncology at the University of Glasgow, grand from Academic Exchange Service
  • 1985 Obtaining a license for medical practice
  • 1987 Defense of the dissertation
  • 1995 Obtaining specialization in internal medicine
  • 1995 Received additional qualifications in the field of hematology and internal oncology (examination of the European Society of Medical Oncology)
  • 2000 Habilitation and a teaching license for internal medicine, University of Rostock
Experience
  • 1986-1987 Department of cardiology and gastroenterology at the Robert Koch Hospital Gehrden
  • 1988-1995 Hannover Medical School
  • 1995-1998 Senior Physician Department of hematology, oncology, and tumor immunology at the Robert Rossle Clinic, Charite Humboldt University Berlin (Director: Univ. Prof. Dr. med. Bernd Dorken)
  • 1998-2001 Senior Physician, Department of internal medicine, Department of hematology, oncology at the University of Rostock (Director: Univ. Prof. Dr. med. Mathias Freund)
  • 2001-2004 C3 Professorship in internal medicine with a focus on internal oncology at the University Clinic Carl Gustav Carus of the Dresden University of Technology (Director: Univ. Prof. Dr. med. Gerhard Ehninger)
  • Director of the Department of oncology and hematology at the University Hospital Oldenburg
  • 2018 Professor of the Department of oncology and hematology at the University Hospital Oldenburg
Awards & Memberships
  • 2001-2007 Secretary at the European Organization for Research and Treatment of Cancer Group
  • Member of the American Association of Cancer Research
  • Member of the Working group for internal oncology
  • Member of the American Society of Clinical Oncology
  • Member of the German Cancer Society
  • Member of the German Society for Hematology and Oncology
  • Member of the Gastrointestinal Group at the European Organization for Research and Treatment of Cancer
  • Member of the European Society of Medical Oncology
  • Member of the Head of the Wilsede School for Oncology, Haematology, Palliative Medicine, Wilsede Academy
  • Member of the International Society of Geriatric Oncology
  • Founding Member of the Pan-European Trial for adjuvant Colon Cancer Initiative
  • Study Coordinator of the Pan-European-Trial for adjuvant Colon Cancer Initiative 2 study
  • Study Coordinator of the European Organization for Research and Treatment of Cancer Studies
  • Editorial Board Member of annals of oncology
  • Advisor to the European Regulatory Authority
  • Advisor to the Institute for Applied Quality Promotion and Research in Health Care

Languages

English flag
English
German flag
German

Publications

Naldemedine versus placebo in opioid-induced constipation: a meta-analysis.

14 December, 2022

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms.

October, 2022

Herpes zoster prophylaxis with low-dose acyclovir in patients with malignant lymphoma and multiple myeloma treated with autologous stem cell transplantation.

September, 2022

Location

Ammerländer Heerstraße, 114-118, 26129 Oldenburg, Germany

FAQ

Where does the doctor practice?

What is the specialization of Prof. Dr. med. Claus-Henning Kohne?

The primary specialization of the doctor is hematology and internal oncology.

What is the experience of the specialist?

Prof. Dr. med. Claus-Henning Kohne has been practicing for more than 39 years.

What is the rating of the doctor?

What topics does Prof. Dr. med. Claus-Henning Kohne expert at?

The doctor has excellent knowledge in cancer, colorectal cancer, metastatic colorectal cancer, chemotherapy, cetuximab.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Prof. Dr. med. Claus-Henning Kohne doesn’t perform virtual appointments.

Prof. Dr. med. Claus-Henning Kohne
Prof. Dr. med. Claus-Henning Kohne

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. med. Claus-Henning Kohne

Similar Doctors

Excellent
AiroScore
9.60
University Hospital Oldenburg
pediatrics, child oncology and hematology
Excellent
AiroScore
10.00
University Hospital Charite Berlin
pediatrics, hematology, oncology, pediatric intensive care
Excellent
AiroScore
10.00
University Hospital Charite Berlin
oncology, haematology, biological therapy of cancer
Excellent
AiroScore
10.00
University Hospital Charite Berlin
gynecology, breast cancer, plastic, and reconstructive operations in gynecology
Excellent
AiroScore
10.00
University Hospital Charite Berlin
haematology, oncology, leukaemia research, tumor immunology
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal, palliative and emergency medicine, hematology, oncology, pain therapy
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal medicine, oncology, and pneumology
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal medicine, hematology, oncology, and rheumatology
Excellent
AiroScore
9.90
University Hospital Saarland Homburg
oncology, hematology, immunology, and rheumatology